Non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in lung tissues. It can be recurrent or metastatic, leading to various symptoms.
Lung Cancer: Nivolumab with Ipilimumab and Chemotherapy
We are studying a new way to administer nivolumab alongside ipilimumab and chemotherapy for patients with untreated metastatic or recurrent lung cancer. The trial aims to understand how the body reacts to this combination and its safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have stage IV lung cancer or recurrent lung cancer?
- Have you had any prior treatment for lung cancer, such as chemotherapy or targeted therapy?
- Do you have any known driver mutations for lung cancer that can be treated with targeted therapy?
- Are you currently taking any medications that suppress your immune system, like corticosteroids?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Abutrax
Alimta
Apexelsin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
GIE Groupe hospitalier Paris Saint-Joseph/Vinci
Service de pneumologie
Montrouge, France
Centr Georges Francois Leclerc
Oncologie médicale
Saint-Apollinaire, France
Hospital Foch
Oncologie médicale
Suresnes, France
Sponsor: Bristol-Myers Squibb Services Unlimited Company
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.